Xcout Intel
Excelsior Sciences
Excelsior Sciences is a biotechnology research company leveraging automated, AI-friendly small molecule synthesis, known as blocc chemistry, to accelerate drug discovery. Headquartered in the United States, the company scales chemical molecule development from discovery to manufacturing.
Subscribe to see Excelsior Sciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Excelsior Sciences at a glance
Excelsior Sciences is a clinics/outpatient services company headquartered in United States. Its most recent funding round, Series A, raised $70M in December 2025. Xcout tracks 8 named people at Excelsior Sciences, including Michael Foley (Co-Founder and Chief Executive Officer).
Excelsior Sciences leadership
- Michael FoleyCo-Founder and Chief Executive Officer
- Jana JensenCo-founder and Chief Operating Officer
- Bartosz Grzybowskico-founder
- Martin BurkeCo-Founder, BOD Member
- Marty Burkeco-founder
- Edward KliphuisBoard Member
2 more named people on record for Excelsior Sciences, with roles, board committees and tenure — see the full roster →
Excelsior Sciences funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $70M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Excelsior Sciences competitors
A few of Excelsior Sciences's closest competitors — see the full list of competitors and alternatives →
CoformerAI is a biotechnology company that specializes in AI-driven drug development and formulation. The company provides solutions designed to improve the solubility, bioavailability, and safety of pharmaceuticals while streamlining the formulation process.
Chemify is a chemical manufacturing company headquartered in Glasgow, Scotland, founded in 2022 to build upon research from the University of Glasgow. The company fuses chemistry, robotics, computation, machine learning, and its own programming language to digitize molecule creation.
Scindo is a UK-based biotech startup headquartered in London that pioneers AI-driven enzyme discovery and engineering to create sustainable alternatives for recycling and waste reduction.
BioReact is an artificial intelligence-driven biotechnology company headquartered in Indianapolis, Indiana. Founded to overcome barriers in bioprocess development, it provides bioprocess analytics software that integrates fragmented scientific data using SaaS and big data tools.
Get Excelsior Sciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Excelsior Sciences in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access